Navigation Links
Slone Partners Places Ingo Chakravarty as President and Chief Executive Officer at Mesa Biotech

Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Ingo Chakravarty as President and Chief Executive Officer (CEO) of Mesa Biotech. Chakravarty assumes leadership of the company less than two months after it received Emergency Use Authorization (EUA) from the Federal Drug Administration (FDA) to market its 30-minute point-of-care (POC) molecular SARS-CoV-2 test.

Chakravarty joins Mesa Biotech with more than 25 years of experience and a proven track record in capital formation and building and leading high-performing organizations in the healthcare industry. He most recently served as President and CEO of NAVICAN Genomics after spending nearly two decades building global businesses in the oncology and infectious disease market. He has held senior leadership positions at GenMark Diagnostics, Gen-Probe, Roche, and Ventana Medical Systems.

Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Similar to Mesa Biotech’s commercially available tests for influenza and RSV, the new rapid Accula™ SARS-CoV-2 test provides actionable, laboratory-quality results at POC with greater sensitivity and specificity than traditional infectious disease rapid immunoassay tests.

“Ingo Chakravarty is an accomplished and passionate leader in the healthcare and medical diagnostics fields, and he will be a tremendously valuable addition to Mesa Biotech’s executive team as the company expands its product line to respond to the COVID-19 pandemic,” said Slone Partners CEO Leslie Loveless.

Dr. William Brody, Chairman of the Board of Mesa Biotech, said, "Mesa Biotech has enhanced its market position with the launch of two FDA cleared products for Flu A/ Flu B and RSV, and the more recent Emergency Use Authorization (EUA) for the 30-minute point-of-care Accula SARS-CoV-2 test. Entering our next phase of growth, Mr. Chakravarty is the right person, at the right time, to lead Mesa Biotech."

"It is remarkable what Mesa Biotech has achieved over the past decade," said Chakravarty. "I am grateful for the opportunity to be part of such a dedicated, high performing team. Together we will seize the opportunity and be part of the global response to the current and any future infectious disease challenges that require us to quickly generate the most accurate diagnostic data possible – anytime, anywhere."

Slone Partners delivers the leaders who build amazing scientific healthcare organizations – People Are Our Science®. Since 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established life sciences, diagnostics, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services to innovative scientific healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit or call 888.784.3422.

Mesa Biotech designs, develops, manufactures and commercializes next generation rapid molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Mesa Biotech's Accula™ Flu A/Flu B and RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA). Both products are distributed in the United States by Sekisui Diagnostics under the Silaris™ brand. Mesa Biotech has also secured a number of strategic agreements for distribution in Europe and Asia. For more information visit

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related medicine news :

1. Slone Partners, Where People Are Our Science®, Places Amol Chaubal As Chief Financial Officer At Quanterix
2. Slone Partners, Where People Are Our Science®, Places G Paul Evans, PhD, as President and CEO of Velocity Clinical Research
3. Slone Partners, Where People Are Our Science®, Places Roy Smythe, M.D. as Chief Executive Officer at SomaLogic, Inc.
4. SLONE PARTNERS Executive Search, Where PEOPLE ARE OUR SCIENCE®, Expands Across California
5. Executive Search Firm Slone Partners Launches New Website
6. Slone Partners Places New Chief Medical Officer at Clinical Genomics
7. Slone Partners Places VP of North American Capital Sales at HTG Molecular Diagnostics
8. Slone Partners Announces Benefactor Sponsorship of Executive War College 2016
9. SLONE PARTNERS Announces Corporate Sponsorship of Molecular Med TRI-CON 2016
10. Slone Partners Places VP of Global Business Development at CollabRx
11. Slone Partners Expands Advisory Board Ahead of Growth in Next Generation Sequencing
Post Your Comments:
(Date:7/10/2020)... ... 2020 , ... 3Lions Publishing, Inc. (3LP), is pleased to ... Portal . Expresso® 3.0 contains a Portal where potential and existing partners fill ... performing other administrative tasks that amount to thousands of dollars per year ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , Future ... trends, news, and products within specific scientific niches. Since their launch four years ...
(Date:7/2/2020)... BEACH, Ala. (PRWEB) , ... July 02, 2020 ... ... recently awarded its annual Outstanding Safety Professional of the Year Award to Eric ... selected Simmons from more than 250 nominations. Simmons, who holds a master’s degree ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... the clinical development of psychedelics and analogues, announces its core executive team. The ... natural product drug discovery, novel formulations, and as distinguished researchers within the cannabis ...
(Date:6/28/2020)... , ... June 26, 2020 , ... PathAI, a global ... results of an exploratory analysis of digital scoring of PD-L1 expression to assess response ... poster #2017 at the 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... July 10, 2020 , ... The Dolphin Company, the ... more than 12 million guests, unveiled its new comprehensive plan of protocols and ... in all facets of the operation, safety, and health addressing COVID-19. , Experts ...
(Date:7/7/2020)... ... July 07, 2020 , ... Nonprofit Team PHenomenal Hope (Team ... Research Award at its first ever virtual research town hall on Saturday, July 11 ... will showcase the latest research in the area of pulmonary hypertension (PH), in focused ...
(Date:7/4/2020)... CANCÚN QUINTANA ROO, México (PRWEB) , ... July ... ... beaches and hotels of the Riviera Maya began to welcome visitors at approved ... which include careful cleaning and sanitizing, among other preventive actions. , The most ...
Breaking Medicine Technology: